Loading markets…

10x Genomics, Inc. (TXG) forecast

10x Genomics, Inc. (TXG) forecast: price $68.35, trailing P/E -128.12, forward P/E 210.31. How to read the street's path.

$68.35Price
$8.91BMarket cap
-128.12P/E ?
210.31Forward P/E ?
0.00%Dividend yield ?

The live TXG price is $68.35. Trailing P/E is -128.12 and forward P/E is 210.31. The forecast that matters is the earnings path those ratios imply, not a single target price.

A forward P/E below the trailing P/E means the consensus expects earnings to rise. The reverse means the market is looking at a peak. Neither is a schedule. Analyst targets are useful as a range of models. They are not a contract. Discounted cash flow is the long form: cash flows, a discount rate, and a terminal value you can argue with.

Use this page for the TXG forecast URL. The prediction page next to it puts the same live inputs in the price-target framing. Both stay in sync with the quote on the main page.

Learn: Forward P/E · Analyst forecast · DCF

Full TXG quote · Dividends · Price prediction · Academy

Questions

What is TXG's forward P/E?

The latest forward P/E on Stocklytics is 210.31, against a trailing P/E of -128.12 and a price of $68.35.

Is the analyst target the forecast?

It is one forecast. The earnings estimate behind it is the part you can track. The target will be revised after the next report.